Camlin Fine Sciences Ltd

Camlin Fine Sciences has experienced notable trading activity, gaining 7.42% on February 19, 2025, and outperforming its sector. The stock is nearing its 52-week high and is trading above key moving averages, indicating a positive trend. Over the past month, it has risen significantly compared to the broader market.

Camlin Fine Sciences reached a new 52-week high of Rs. 150.95, reflecting strong performance in the small-cap chemicals sector. The stock has outperformed its sector significantly over the past year, with a notable return of 35.05%, contrasting sharply with the Sensex's 4.62% performance.

Camlin Fine Sciences, a small-cap chemicals company, experienced notable trading activity on February 17, 2025, reaching a new 52-week high. The stock outperformed its sector significantly, trading above multiple moving averages and demonstrating strong gains over the past month, contrasting with a decline in the broader market.

Camlin Fine Sciences has announced its financial results for the quarter ending December 2024, reporting a significant year-on-year increase in Profit After Tax at Rs 46.67 crore. The company achieved its highest quarterly net sales in five quarters at Rs 433.49 crore, alongside improved operating profit margins, despite rising interest costs and liquidity concerns.

Camlin Fine Sciences has reached a new 52-week high of Rs. 144.4, outperforming its sector by 1.76%. The stock has gained 5.53% in the last two days and has delivered a 13.73% return over the past year, significantly exceeding the Sensex's 7.62% performance.

Camlin Fine Sciences has reached a new 52-week high, showcasing strong performance in the small-cap chemicals sector. The stock has shown a notable upward trend over the past four days and is currently trading above multiple moving averages, outperforming the Sensex over the past year.

Camlin Fine Sciences, a small-cap chemicals company, experienced a notable gain on January 14, 2025, following a four-day decline, indicating a possible trend reversal. The stock outperformed its sector and showed a significant monthly appreciation, contrasting with the broader market's performance.

Camlin Fine Sciences, a small-cap chemicals company, experienced a significant stock price decline on January 13, 2025, amid broader market trends. Despite recent challenges, the company has shown a positive return over the past month, contrasting with the overall performance of the Sensex.

Camlin Fine Sciences has undergone a revision in its score following recent market activity. Despite a notable decline in stock price, the company has shown resilience with a positive monthly performance, outpacing the broader market. Additionally, it has been added to MarketsMOJO's list, highlighting its potential amidst current challenges.

Camlin Fine Sciences has seen a revision in its score following a strong performance, closing at Rs 139.9 after an 8.76% increase. The stock has been added to MarketsMOJO's list, reflecting its positive market position and resilience, outperforming both its sector and broader market indices in recent weeks.

Camlin Fine Sciences has recently seen a revision in its score following a significant rise in its stock price, which surged on January 1, 2025. The company has been added to MarketsMOJO's list, reflecting its strong performance metrics and consistent upward momentum, outperforming both its sector and broader market indices.

Camlin Fine Sciences has recently experienced a revision in its score, reflecting its strong performance in the chemicals sector. The stock has shown notable gains, outperforming its sector and trading above key moving averages. Additionally, it has been added to MarketsMOJO's list, highlighting its upward momentum.

Camlin Fine Sciences, a smallcap company in the chemicals industry, saw a 7.11% increase in its stock performance on November 18, 2024, outperforming the sector by 6.98%. This marks the second consecutive day of gains, with a total rise of 13.16% in the past two days. The stock is currently trading above its moving averages and has outperformed the Sensex by 7.48%. However, it is important to note that the company's past performance does not reflect any future potential.

On November 14, 2024, Camlin Fine Sciences, a smallcap chemicals company, saw a 7.36% rise in its stock price, outperforming the sector by 6.18%. Despite being rated as a 'Strong Sell' by MarketsMOJO, the stock showed a potential trend reversal with a significant increase and trading above its moving averages.

Camlin Fine Sciences, a smallcap chemical company, has reported a flat performance in the second quarter of fiscal year 2024-2025. However, there has been a significant improvement in the company's score and profit after tax has seen a growth of 362.2% year on year. The company's non-operating income and debt-equity ratio have raised concerns.

Camlin Fine Sciences, a smallcap chemicals company, saw a decline in its stock price on October 25th, 2024, with a -7.38% loss and an intraday low of Rs 98.7. According to MarketsMOJO, the stock call is currently 'Strong Sell' due to trading below multiple moving averages and the chemicals sector falling by -2.02%. Compared to the overall market, Camlin Fine Sciences' stock performance has been lower on both a 1 day and 1 month basis. Investors should conduct their own research before making any investment decisions.

On October 16th, 2024, Camlin Fine Sciences, a smallcap company in the chemicals industry, saw a positive performance with an 8.02% increase in stock price, outperforming the sector by 5.19%. However, MarketsMOJO has given a 'Strong Sell' call due to the stock's higher moving averages, potentially indicating a downward trend. Camlin Fine Sciences has also outperformed the Sensex in the past day and month, but both have seen declines. It is important to conduct thorough research and consult with a financial advisor before making any investment decisions.

Camlin Fine Sciences, a smallcap chemicals company, reported a negative performance in the quarter ending June 2024 with a score of -14, indicating a downward trend. Major factors contributing to this include a significant decline in PBT and PAT, as well as a rise in interest cost and a decline in sales. The company will need to address these issues to improve its financials in the future.

Camlin Fine Sciences, a smallcap chemicals company, saw a 7.67% increase in its stock price on July 26, 2024, outperforming the sector by 3.33%. This marks the third consecutive day of gains, with a total increase of 12.29%. The stock is currently trading above its moving averages, indicating a positive trend.